Market Place
Sourcing Support
Pharmactive Biotech`s Complex Supports Prostate Health Study
15 Oct 2024 //
PR NEWSWIRE
Annual General Meeting of Active Biotech AB
19 May 2022 //
GLOBENEWSWIRE
Annual Report 2021 Active Biotech AB (publ)
28 Apr 2022 //
GLOBENEWSWIRE
Active Biotech strengthens the patent protection for laquinimod in eye disorders
25 Apr 2022 //
GLOBENEWSWIRE
Active Biotech Interim Report Q1 2022
21 Apr 2022 //
GLOBENEWSWIRE
Active Biotech: NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
20 Apr 2022 //
GLOBENEWSWIRE
Number of shares and votes in Active Biotech
31 Mar 2022 //
GLOBENEWSWIRE
Correction: Active Biotech Year End Report 2021
25 Mar 2022 //
GLOBENEWSWIRE
Active Biotech inks global patent license agreement with Oncode Institute
11 Feb 2022 //
PHARMABIZ
Active Biotech: Year End Report 2021
09 Feb 2022 //
GLOBENEWSWIRE
Active Biotech Begins Dosing in comb. part of phase Ib/IIa study of tasquinimod
07 Feb 2022 //
GLOBENEWSWIRE
Active Biotech’s partner NeoTX to Present at the Society for (SITC)
09 Nov 2021 //
GLOBENEWSWIRE
Active Biotech and NeoTX today announce that the first patient has been enrolled
20 Oct 2021 //
GLOBENEWSWIRE
Active Biotech’s partner NeoTX will host KOL webinar
08 Jul 2021 //
GLOBENEWSWIRE
Active Biotech provides status update of its clinical naptumomab project
05 Jul 2021 //
GLOBENEWSWIRE
Active Biotech and NeoTX announce FDA Clearance of IND for Phase II Clinical
19 Apr 2021 //
GLOBENEWSWIRE
CDMO Famar and Active Biotech Ink Clinical Manufacturing Deal
04 Feb 2021 //
PRESS RELEASE
Active Biotech announces first patient dosed in ph 1b/2a study of tasquinimod
03 Aug 2020 //
GLOBENEWSWIRE
Active Biotech provides status update in the portfolio projects
02 Jun 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.